Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 31.5.2023Pfizer Europe MA EEIG (PFI-BE-3)39626TOVIAZ 8 mg tablety s predĺženým uvoľňovaním (tbl plg 28x8 mg (blister Al/Al))4.9.2023R
 31.5.2023Pfizer Europe MA EEIG (PFI-BE-3)39621TOVIAZ 4 mg tablety s predĺženým uvoľňovaním (tbl plg 28x4 mg (blister Al/Al))24.7.2023R
 31.5.2023Novartis Europharm Limited (NEH-IE)3591DMayzent 0,25 mg filmom obalené tablety (tbl flm 120x0,25 mg (PA/Al/PVC/Al))31.7.2023Z
 31.5.2023Zentiva, k.s. (ZNT-1)2529DDasatinib Zentiva 70 mg filmom obalené tablety (tbl flm 60x70 mg (blis.OPA/Al/PVC/Al))31.5.2023R
 31.5.2023Zentiva, k.s. (ZNT-1)5805BMixor 80 mg/5 mg (tbl 90x80 mg/5 mg (blis.OPA/Al/PVC/Al))31.5.2023R
 31.5.2023Zentiva, k.s. (ZNT-1)5811BMixor 80 mg/10 mg (tbl 90x80 mg/10 mg (blis.OPA/Al/PVC/Al))31.5.2023R
 31.5.2023Zentiva, k.s. (ZNT-1)81777Valzap 160 mg (tbl flm 84x160 mg (blis.PVC/PE/PVDC/Al))31.5.2023R
 31.5.2023Zentiva, k.s. (ZNT-1)84766Rosucard 40 mg filmom obalené tablety (tbl flm 30x40 mg (blis.OPA/Al/PVC/Al))31.5.2023R
 31.5.2023Zentiva, k.s. (ZNT-1)87162Tezeo 80 mg (tbl 90x80 mg (blis.OPA/Al/PVC/Al))31.5.2023R
 31.5.2023Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))31.5.2023R
 31.5.2023MEDOCHEMIE Ltd. (MOE)0332BCONVERIDE 300 mg/12,5 mg (tbl flm 28x300 mg/12,5 mg (blis.PVC/PVDCAl-nepriehľ.))1.6.2023O
 31.5.2023MEDOCHEMIE Ltd. (MOE)33522MEDOCLAV 625 mg (tbl flm 21x625 mg (blis.Al/PVC))1.6.2023R
 31.5.2023MEDOCHEMIE Ltd. (MOE)37109ARKETIS 30 mg (tbl 30x30 mg (blis.PVC/Al))1.6.2023R
 31.5.2023MEDOCHEMIE Ltd. (MOE)39164MEDOCLAV 1 g (tbl flm 14x1 g (blis.Al/PVC))1.6.2023R
 31.5.2023MEDOCHEMIE Ltd. (MOE)40203KLERIMED 500 mg (tbl flm 14x500 mg (blis.PVC/PVDC/Al))1.6.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)